GBM84 GBM Model

GBM84, a Patient-Derived Xenograft (PDX) model, is your gateway to brain cancer research. Investigate its features to unlock new discoveries and advance the development of effective treatments. PDX models like GBM84 offer an indispensable platform for preclinical drug discovery. By preserving the genetic and histological features of the patient tumor, GBM84 enables researchers to evaluate a wide range of drug candidates efficiently. This accelerates the development of targeted therapies and holds promise for improved outcomes for brain cancer patients.

Model Details

Cancer Location: Intracranial
Cancer Type: Brain Cancer
Model Name: GBM84
Mouse Strain: Nu/Nu
Treatment Data Available: Chemotherapy (Temozolomide)
WES: Yes
RNAseq: Yes
Methylation: Yes
PDX Treatment: Yes
Patient Treatment History: Yes

GMB84 Survival

Survival of orthotopic intracranial implanted  GBM84 in Nu/Nu mice  (n=5)

Request Additional GBM Model Data

Contact Us

Get Started.

Have questions about how TD2 can assist with your regulatory needs? Reach out to our
expert staff today to get started.

Skip to content